| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue | 1,341 | 1,118 | 16,671 | | Cost of Revenue | 7,003 | 9,660 | 12,596 | | | Gross Profit | (5,662) | (8,542) | 4,075 | | | Operating Expenses | | Research Development | 4,668 | 4,652 | 15,044 | | Selling General and Administrative | 10,380 | 15,059 | 26,673 | | Non Recurring | 3,133 | 603 | 6,407 | | Others |
-
|
-
| 3,045 | | | | Total Operating Expenses |
-
|
-
| 51,169 | | | | Operating Income or Loss | (23,843) | (28,856) | (47,094) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,257 | 1,815 | 2,267 | | Earnings Before Interest And Taxes | (22,586) | (27,041) | (44,827) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (22,586) | (27,041) | (44,827) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (22,586) | (27,041) | (44,827) | | | Non-recurring Events | | Discontinued Operations |
-
| 17,945 |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (22,586) | (9,096) | (44,827) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($22,586) | ($9,096) | ($44,827) |
|
0.51% Nasdaq 
0.0025 (1.06%) 
Income Statement
